| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.31 | 0.1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |